Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA review
Biotech
FDA delays force Daré to shelve phase 3 plans: WSJ
In the last two months, the FDA has pushed back the date it would provide guidance twice, according to Daré's CEO.
Gabrielle Masson
Apr 17, 2025 3:03pm
Biotech CEOs say they already feel impact of FDA restructure
Apr 10, 2025 1:56pm
FDA leadership 'decapitated,' former leader Janet Woodcock says
Apr 7, 2025 4:04pm
ReCor Medical taps Siemens Healthineers alum as CEO
Jan 3, 2023 12:04pm
As FDA funding debated, CDER chief makes a pitch for new hires
Apr 5, 2022 10:00am
Calls for probe into 'inappropriate' FDA-Biogen collaboration
Apr 5, 2021 8:35am
